Literature DB >> 19909766

Size-dependent effects of nanoparticles on the activity of cytochrome P450 isoenzymes.

Eleonore Fröhlich1, Tatjana Kueznik, Claudia Samberger, Eva Roblegg, Christopher Wrighton, Thomas R Pieber.   

Abstract

Nanoparticles are known to be able to interfere with cellular metabolism and to cause cytotoxicity and moreover may interfere with specific cellular functions. Serious effects on the latter include changes in liver cell function. The cytochrome P450 system is expressed in many cells but is especially important in hepatocytes and hormone-producing cells. The interaction of polystyrene nanoparticles with the most important drug-metabolizing cytochrome P450 isoenzymes, CYP3A4, CYP2D6, CYP2C9 and CYP2A1 expressed individually in insect cells (BACULOSOMES was studied by the cleavage of substrates coupled to a fluorescent dye. The data obtained for individual isoenzymes were compared to metabolism in microsomes isolated from normal liver and from the hepatoma cell line H4-II-E-C3. Small (20-60 nm) carboxyl polystyrene particles but not larger (200 nm) ones reached high intracellular concentrations in the vicinity of the endoplasmic reticulum. These small particles inhibited the enzymatic activity of CYP450 isoenzymes in BACULOSOMES and substrate cleavage in normal liver microsomes. They moreover increased the effect of known inhibitors of the cytochrome P450 system (cimetidine, phenobarbital and paclitaxel). Substrate cleavage by the hepatoma cell line H4-II-E-C3 in contrast was undetectable, making this cell line unsuitable for this type of study. Our results thus demonstrate that nanoparticles can inhibit the metabolism of xenobiotics by the CYP450 system in model systems in vitro. Such inhibition could also potentially occur in vivo and possibly cause adverse effects in persons receiving medication. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19909766     DOI: 10.1016/j.taap.2009.11.002

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  25 in total

1.  Inhibition of cytochrome P450 2B4 by environmentally persistent free radical-containing particulate matter.

Authors:  James R Reed; Albert Leo N dela Cruz; Slawo M Lomnicki; Wayne L Backes
Journal:  Biochem Pharmacol       Date:  2015-03-24       Impact factor: 5.858

Review 2.  Biomarkers of susceptibility: State of the art and implications for occupational exposure to engineered nanomaterials.

Authors:  Ivo Iavicoli; Veruscka Leso; Paul A Schulte
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-24       Impact factor: 4.219

3.  Environmentally persistent free radical-containing particulate matter competitively inhibits metabolism by cytochrome P450 1A2.

Authors:  James R Reed; Albert Leo N dela Cruz; Slawo M Lomnicki; Wayne L Backes
Journal:  Toxicol Appl Pharmacol       Date:  2015-09-28       Impact factor: 4.219

4.  Environmentally persistent free radicals inhibit cytochrome P450 activity in rat liver microsomes.

Authors:  James R Reed; George F Cawley; Taylor G Ardoin; Barry Dellinger; Slawomir M Lomnicki; Farhana Hasan; Lucy W Kiruri; Wayne L Backes
Journal:  Toxicol Appl Pharmacol       Date:  2014-04-05       Impact factor: 4.219

Review 5.  Toxicity of nanomaterials.

Authors:  Shahriar Sharifi; Shahed Behzadi; Sophie Laurent; M Laird Forrest; Pieter Stroeve; Morteza Mahmoudi
Journal:  Chem Soc Rev       Date:  2011-12-14       Impact factor: 54.564

6.  Nanoparticles for local drug delivery to the oral mucosa: proof of principle studies.

Authors:  Andrew S Holpuch; Garrett J Hummel; Meng Tong; Garrett A Seghi; Ping Pei; Ping Ma; Russell J Mumper; Susan R Mallery
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

7.  Impact of iron oxide nanoparticles on xenobiotic metabolism in HepaRG cells.

Authors:  Linn Voss; Kiymet Yilmaz; Lea Burkard; Janja Vidmar; Valerie Stock; Ute Hoffmann; Oliver Pötz; Helen Sophie Hammer; Matthias Peiser; Albert Braeuning; Katrin Löschner; Linda Böhmert; Holger Sieg
Journal:  Arch Toxicol       Date:  2020-09-10       Impact factor: 5.153

8.  Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) Enzymes.

Authors:  Narasimha M Midde; Santosh Kumar
Journal:  J Pers Nanomed       Date:  2015-09-10

Review 9.  Mode of action of nanoparticles against insects.

Authors:  Giovanni Benelli
Journal:  Environ Sci Pollut Res Int       Date:  2018-04-03       Impact factor: 4.223

Review 10.  Enzymatic oxidative biodegradation of nanoparticles: Mechanisms, significance and applications.

Authors:  Irina I Vlasova; Alexandr A Kapralov; Zachary P Michael; Seth C Burkert; Michael R Shurin; Alexander Star; Anna A Shvedova; Valerian E Kagan
Journal:  Toxicol Appl Pharmacol       Date:  2016-01-06       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.